Avadel Pharma (AVDL) Reports Q4 Loss of $0.46/Share

Avadel Pharma (NASDAQ: AVDL) reported Q4 EPS of ($0.46), versus ($0.25) reported last year. Revenue for the quarter came in at $20.9 million, versus $34.75 million reported last year.

For earnings history and earnings-related data on Avadel Pharma (AVDL) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)
• DA Davidson Reiterates Buy Rating on Boost Run (BRUN)